Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Mol Pain ; 17: 17448069211033172, 2021.
Article in English | MEDLINE | ID: mdl-34284652

ABSTRACT

Fabry disease (FD) is a progressive, X-linked inherited disorder of glycosphingolipid metabolism due to deficient or absent lysosomal α-galactosidase A (α-Gal A) activity which results in progressive accumulation of globotriaosylceramide (Gb3) and related metabolites. One prominent feature of Fabry disease is neuropathic pain. Accumulation of Gb3 has been documented in dorsal root ganglia (DRG) as well as other neurons, and has lately been associated with the mechanism of pain though the pathophysiology is still unclear. Small fiber (SF) neuropathy in FD differs from other entities in several aspects related to the perception of pain, alteration of fibers as well as drug therapies used in the practice with patients, with therapies far from satisfying. In order to develop better treatments, more information on the underlying mechanisms of pain is needed. Research in neuropathy has gained momentum from the development of preclinical models where different aspects of pain can be modelled and further analyzed. This review aims at describing the different in vitro and FD animal models that have been used so far, as well as some of the insights gained from their use. We focus especially in recent findings associated with ion channel alterations -that apart from the vascular alterations-, could provide targets for improved therapies in pain.


Subject(s)
Fabry Disease , Animals , Fabry Disease/complications , Ganglia, Spinal/metabolism , Humans , Ion Channels , Pain , alpha-Galactosidase/metabolism
2.
PLoS One ; 12(1): e0169422, 2017.
Article in English | MEDLINE | ID: mdl-28046078

ABSTRACT

Ruminants are the primary reservoir of Shiga-toxin producing Escherichia coli (STEC) O157:H7 and the main source of infection for humans. The aim of this study was to assess the immunogenic properties of a candidate vaccine consisting on the recombinant proteins of E. coli O157:H7 IntiminC280, the carboxy-terminal fraction of Intimin γ, EspB and the fusion protein between the B subunit of Stx2 and Brucella Lumazine Synthase (BLS)(BLS-Stx2B), in Holstein Fresian calves.To accomplish this goal we vaccinated calves with two doses of different vaccine formulations: 2 antigens (IntiminC280, EspB), 3 antigens (IntiminC280, EspB, BLS-Stx2B), BLS-Stx2B alone and a control non-vaccinated group. All antigens were expressed as recombinant proteins in E. coli. Specific IgG titres increased in vaccinated calves and the inclusion of BLS-Stx2B in the formulation seems to have a stimulatory effect on the humoral response to IntiminC280 and EspB after the booster. The neutralizing activity of antibodies against these two antigens was assessed in Red Blood Cell lysis assays and adherence to Hep-2 cells as a correlate of T3SS activity. Both sera from animals vaccinated with 2 or 3 antigens inhibited both virulence properties. Serological response to Stx2 was observed in animals vaccinated only with BLS-Stx2B and with 3 antigens and neutralization of Stx2 cytotoxicity was also observed in both groups. In conclusion, immunization of calves with BLS-Stx2B, IntiminC280 and EspB elicited a potent humoral response able to neutralize Shiga toxin 2 cytotoxity and the T3SS virulence properties in vitro. These results suggest that this formulation is a good candidate vaccine to reduce STEC shedding in cattle and needs to be further assessed in vivo.


Subject(s)
Cattle Diseases/immunology , Cattle/immunology , Escherichia coli Infections/veterinary , Escherichia coli Vaccines/immunology , Shiga Toxin 2/immunology , Type III Secretion Systems , Adhesins, Bacterial/metabolism , Animals , Antibodies, Bacterial/blood , Bacterial Outer Membrane Proteins/metabolism , Bacterial Shedding , Cattle Diseases/microbiology , Cell Adhesion , Chlorocebus aethiops , Erythrocytes/microbiology , Escherichia coli Infections/immunology , Escherichia coli O157/pathogenicity , Escherichia coli Proteins/metabolism , Immunity, Humoral , Immunoglobulin G/blood , Male , Recombinant Proteins/immunology , Vero Cells , Virulence
3.
Parasitol Res ; 110(3): 1103-12, 2012 Mar.
Article in English | MEDLINE | ID: mdl-21845411

ABSTRACT

The aim of the present work was to determine the in vitro effect of Mentha piperita and Mentha pulegium essential oils against Echinococcus granulosus and to compare the effectiveness of both oils according to the exposure time and concentration. Although both treatments had a protoscolicidal effect, M. pulegium had a considerably stronger effect than M. piperita. Essential oil of M. pulegium produced dose- and time-dependent effects. Maximal protoscolicidal effect was observed after 12 days of incubation and reached 0% after 18 days. This lack of viability was proved during the determination of infectivity into mice. Essential oil of M. piperita produced only a time-dependent effect. At 24 days p.i., the viability of protoscoleces decreased to approximately 50%. Scanning and transmission electron microscopy (SEM and TEM) demonstrated the drug-induced ultrastructural damage. On the other hand, a loss of turgidity was detected in all M. pulegium-treated cysts respective of the drug concentration. There was a correlation between the intensity of damage and the concentration of the essential oil assayed. Studies by SEM revealed that the germinal layer of treated cysts lost the feature multicellular structure. M. pulegium essential oil showed piperitone oxide as main compound in their composition, and we suggest that this component could be responsible of the markedly anthelmintic effect detected. Our data suggest that essential oils of Mentha spp. can be a promising source of potential protoscolicidal agents. The isolation of active anthelmintic constituents is in progress and may lead to the discovery of compounds with improved therapeutic value.


Subject(s)
Anthelmintics/pharmacology , Echinococcus granulosus/drug effects , Echinococcus granulosus/growth & development , Mentha piperita/chemistry , Mentha pulegium/chemistry , Oils, Volatile/pharmacology , Animals , Anthelmintics/chemistry , Dose-Response Relationship, Drug , Echinococcosis/drug therapy , Echinococcosis/parasitology , Echinococcus granulosus/pathogenicity , Echinococcus granulosus/ultrastructure , Female , Mice , Microscopy, Electron, Scanning , Microscopy, Electron, Transmission , Oils, Volatile/chemistry , Parasitic Sensitivity Tests , Phytotherapy , Plant Oils/chemistry , Plant Oils/pharmacology , Species Specificity , Survival Analysis , Time Factors
SELECTION OF CITATIONS
SEARCH DETAIL
...